United States· US:49702-250_9a0bc98a-3305-43f1-85bf-fb1e9ba88d45
Rukobia
A other antivirals product containing fostemsavir tromethamine, registered in United States by ViiV Healthcare Company. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Fostemsavir tromethamine is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AX (other antivirals), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Fostemsavir tromethamine · ATC J05AX
4 / 19 countries
- Canada
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- fostemsavir tromethamine
- Manufacturer
- ViiV Healthcare Company
- Country
- United States (US)
- ATC code
- J05AX
- ATC class
- Other antivirals
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1149702250181 BOTTLE in 1 CARTON (49702-250-18) / 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Regulatory notes
Same medicine, other countries
Fostemsavir tromethamine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRukobiaViiV Healthcare BV
- CzechiaRUKOBIAViiV Healthcare BV, Amersfoort
- SwitzerlandRukobia 600 mg, RetardtablettenViiV Healthcare GmbH
- SpainRUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADAViiv Healthcare B.V.
- FranceRUKOBIA 600 mg, comprimé à libération prolongéeVIIV HEALTHCARE (PAYS-BAS)
- United KingdomRukobia 600mg modified-release tabletsViiV Healthcare UK Ltd
- IrelandRukobia 600 mg prolonged-release tabletsViiV Healthcare BV
- IcelandRukobiaViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rukobia
- Liechtenstein · Rukobia
- Norway · Rukobia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/77c330e9-2e6d-4057-acac-5731c3c67785 GET /v1/drugs/77c330e9-2e6d-4057-acac-5731c3c67785?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "2X513P36U0",
"rxcui": "2380374",
"inchikey": "RRGJSMBMTOKHTE-UHFFFAOYSA-N",
"display_name": "FOSTEMSAVIR TROMETHAMINE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"a21006b7-6d6f-4f06-81b4-17978756452b": {
"match": "brand_token",
"title": "RUKOBIA (FOSTEMSAVIR TROMETHAMINE) TABLET, FILM COATED, EXTENDED RELEASE [VIIV HEALTHCARE COMPANY]",
"spl_version": "8",
"published_date": "2025-06-12"
}
},
"productid": "49702-250_9a0bc98a-3305-43f1-85bf-fb1e9ba88d45",
"productndc": "49702-250",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"orange_book": {
"appl_no": "212950",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 600MG BASE",
"product_no": "001",
"approval_date": "Jul 2, 2020"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "FOSTEMSAVIR TROMETHAMINE",
"proprietary_name": "Rukobia",
"active_ingred_unit": "mg/1",
"application_number": "NDA212950",
"marketing_category": "NDA",
"nonproprietary_name": "fostemsavir tromethamine",
"start_marketing_date": "20200702",
"active_numerator_strength": "600"
}See everything about fostemsavir tromethamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.